
OpenAI is reportedly working on a smart speaker that will incorporate its ChatGPT technology, with plans to release it in 2027. The device will not have a screen but will include a camera and sensors to better understand its surroundings. It will feature GPT-Live, OpenAI's latest voice model, and offer capabilities such as smart home control and media playback. This development marks OpenAI's first major foray into hardware, in collaboration with former Apple designer Jony Ive. The move signals OpenAI's ambition to expand its AI applications into consumer devices.
Read original
© The Verge AISpaceXAI's Grok Build AI tool was discovered to be uploading entire user codebases to Google Cloud, including files that were supposed to be excluded and sensitive information. This practice went beyond typical data retention norms, raising significant privacy concerns. After the issue was reported by Cereblab, SpaceXAI disabled the feature, and Elon Musk assured users that all previously uploaded data would be deleted. This situation underscores the critical need for robust data privacy measures in AI tools, especially those handling proprietary and sensitive data. The incident serves as a reminder of the potential risks associated with excessive data retention in AI development environments. SpaceXAI's response and Musk's commitment to data deletion reflect the importance of transparency and user control over data.
© The Verge AIMeta is under legal scrutiny as 26 former employees allege the company used AI tools to unfairly target workers on leave for layoffs. The lawsuit claims that Meta's internal AI systems, including Metamate, ranked employee performance without considering protected leaves, leading to biased decisions. This situation brings attention to the risks of using AI for critical HR tasks, especially when legal protections are involved. Meta refutes the allegations, maintaining that human judgment was central to the layoff process. The case could have significant implications for how AI is integrated into workforce management.
© The Verge AIGoogle is transforming its Images homepage into a dynamic, personalized gallery, marking a significant shift from its traditional search bar interface. This new feature will present users with a curated selection of images tailored to their interests, reminiscent of platforms like Pinterest. Additionally, Google Search will soon leverage its Nano Banana 2 Lite AI model to generate images in AI Overviews, enhancing visualization capabilities for users. These updates aim to make image discovery more intuitive and engaging, offering a more interactive experience for users even before they initiate a search.
© SiftedNeko Health has successfully raised $700 million in Series C funding, marking a pivotal moment for the company. With 100,000 members and profitability at the clinic level, this funding round is a testament to the company's robust growth and operational success. The investment is set to drive further expansion and innovation in their healthcare services, potentially reshaping the landscape of healthcare delivery. Neko Health's strategic position in the health tech industry is strengthened by this substantial financial backing, which reflects strong investor belief in its business model and future trajectory.
© SiftedMeticulous, a London-based startup, has secured $15 million in Series A funding to advance its AI-driven code testing platform. Founded by ex-Palantir and Dropbox engineers, the company aims to streamline the process of verifying AI-generated code by simulating user flows and identifying edge cases. This approach allows developers to quickly understand the impact of code changes, potentially accelerating the deployment process. With plans to expand into backend testing and grow its team, Meticulous is positioning itself as a key player in the AI code verification space.
© TechCrunch AIMiles Wang, an OpenAI researcher, is reportedly leaving to start a new AI-driven drug discovery company, potentially valued at $2 billion. This move highlights the growing trend of applying AI to accelerate breakthroughs in life sciences, with Wang's startup aiming to repurpose existing drugs for new uses. While the funding details are still in flux, the interest from investors like Lightspeed shows the potential impact of AI in the pharmaceutical industry. If successful, Wang's venture could significantly reduce the time and cost associated with bringing new treatments to market.